InvestorsHub Logo
Followers 58
Posts 3934
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Thursday, 10/21/2021 11:09:19 AM

Thursday, October 21, 2021 11:09:19 AM

Post# of 425845
$AMRN So, going over the transcript of the oral arguments, what do you folks make of this statement by Hikma's Counselor in regard to their Label?

Quote: "And with regard to that CV limitation of use, there's no CV limitation of use in the new VASCEPA label. And so it's not as though Hikma carved that out. It doesn't exist anymore. And so -- and under the statute, and I have a slide on this, under the statute, the generic is supposed to copy the branded label." Un-quote



Yes, BUT the generic is supposed to copy the branded label of the indication that the generic is approved for and NOT the new indication that is patented and in this suit.!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News